# QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery

> **NCT03339284** · PHASE4 · UNKNOWN · sponsor: **Tampere University Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Postoperative Pain
- Chronic Pain Post-Proceduraal
- Nausea and Vomiting, Postoperative

## Interventions

- **DRUG:** Dexamethasone sodium phosphate
- **DRUG:** Ropivacaine Hydrocloride
- **DRUG:** Sodium Chloride 9mg/mL

## Key facts

- **NCT ID:** NCT03339284
- **Lead sponsor:** Tampere University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-12-04
- **Primary completion:** 2022-12-31
- **Final completion:** 2023-06-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2021-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03339284

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03339284, "QLB and Laparoscopic Nephrectomy, Postoperative Pain and Recovery". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03339284. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*